Aster Insights
Satya Mudiam's work experience begins with their current position as Director of Data & ML Engineering at M2GEN, starting in April 2022. Prior to this role, they held the position of Director, Data Science at Clairvoyant from September 2020 to March 2022. They also served as an Engineering Manager at Clairvoyant from October 2016 to September 2020.
Before joining Clairvoyant, Satya worked as a Senior Software Engineer at Blackboard from December 2015 to September 2016. Prior to this, they held the position of Engineering Manager at Clairvoyant LLC from October 2013 to November 2015.
Their previous work experience includes being a Lead Software Engineer at Apollo Education Group from February 2009 to October 2013 and a Senior Software Engineer at GoDaddy from June 2008 to January 2009. Earlier in their career, they worked as a Software Engineer at Healthways from May 2007 to June 2008 and at Advertising Checking Bureau from August 2005 to May 2007.
Satya Mudiam earned a Master of Business Administration (M.B.A.) degree from the University of Phoenix between 2012 and 2014. Prior to that, Satya completed a Master of Science (M.S.) in Digital Electronics and Communications from Visvesvaraya Technological University. Additionally, Satya obtained various certifications, including "Python for Genomic Data Science" and "Genomic Data Science with Galaxy" from Coursera in 2017, "Certified Developer on Apache Spark" from O'Reilly in 2015, and "Cloudera Certified Developer for Apache Hadoop" from Cloudera in 2014.
This person is not in any offices
Aster Insights
We believe that personalized medicine starts with a complete view of an individual across their lifetime. Our company was founded in 2006 on the unique principle that informed consent from patients entrusting us with a lifetime connection to their health information, paired with deep partnerships across academia and the life sciences industry, would unlock critical advances in curing cancer. Aster Insights leads the Oncology Research Information Exchange Network (ORIEN®), a consortium of the nation’s leading academic cancer centers that conduct Total Cancer Care®, the world’s largest and longest running observational research study in oncology. TCC® serves as the foundation for novel insights that power oncology breakthroughs. As a long-time innovator in oncology, Aster Insights has world-class expertise in accelerating the life cycle of oncology medical product development. Our solutions are based on scientific and clinical intelligence and strengthened by our unique partnership with patients, academia, and industry. We empower our partners to uncover new targets and biomarkers, enhance cancer detection, deepen our understanding of new treatments, discover new indications, and accelerate clinical trials. Together, we are changing the way cancer is studied, treated, and prevented.